Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) increased in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 87.50% over the past year to $0.15, which beat the estimate of $0.14.
Revenue of $67,653,000 rose by 11.03% from the same period last year, which beat the estimate of $64,000,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
The upcoming fiscal year's revenue expected to be between $270,000,000 and $300,000,000.
How To Listen To The Conference Call
Date: Feb 10, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/3jdd3b89
Price Action
52-week high: $16.29
Company's 52-week low was at $7.12
Price action over last quarter: Up 40.22%
Company Description
Vanda Pharmaceuticals Inc is a biopharmaceutical company which is engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant (VLY-686), VTR-297, and VQW-765.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!